Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 5 Issue: 7, October

Ion Channels as Important Targets for Antiepileptic Drug Design

Volume:5   Issue: 7
Pp: 589-602
P. Yogeeswari, J. Vaigunda Ragavendran, R. Thirumurugan, A. Saxena and D. Sriram
DOI: 10.2174/1389450043345227
Published on: 01 March, 2012

Microglia-Targeted Pharmacotherapy in Retinal Neurodegenerative Diseases

Volume:5   Issue: 7
Pp: 619-627
Erik Schuetz and Solon Thanos
DOI: 10.2174/1389450043345164
Published on: 01 March, 2012

In Vivo MRI in Different Models of Experimental Epilepsy

Volume:5   Issue: 7
Pp: 629-636
P. F. Fabene and A. Sbarbati
DOI: 10.2174/1389450043345218
Published on: 01 March, 2012

Clinical Pharmacotherapy for Obesity: Current Drugs and Those in Advanced Development

Volume:5   Issue: 7
Pp: 637-646
Jason C.G. Halford
DOI: 10.2174/1389450043345191
Published on: 01 March, 2012

Traumatic Injury to CNS Fiber Tracts - What are the Genes Telling Us?

Volume:5   Issue: 7
Pp: 647-654
Daniel Abankwa and Patrick Kury
DOI: 10.2174/1389450043345182
Published on: 01 March, 2012

Psychosocial Conditions and the Efficacy of Clinically Available Anxiolytics

Volume:5   Issue: 7
Pp: 655-664
Jozsef Haller, Jozsef Halasz and Eszter Majercsik
DOI: 10.2174/1389450043345173
Published on: 01 March, 2012